You have no items in your shopping cart.
Biotinylated Human ACE-2 [orb2993139]Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 86.2 KDa. Observed: 110-140 KDa, reducing conditions
20 μg, 100 μg- Human ACE-2 [orb2993140]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 110.5 KDa. Observed: 110-140 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - B.subtilis B.subtilis sfp [orb2993162]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.2 KDa. Observed: 28 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human TDT [orb2993012]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 60.7 KDa. Observed: 62 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse Legumain [orb2993235]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.7 KDa. Observed: 60 KDa, reducing conditions
50 μg, 1 mg, 10 μg, 500 μg - Human UBE2M [orb2993329]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.9 KDa. Observed: 20 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human UBE2K [orb2993330]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 34.5 KDa. Observed: 38 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Human UBE2V1 [orb2993334]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.5 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2Z [orb2993335]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 30.2 KDa. Observed: 32 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2L6 [orb2993337]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.8 KDa. Observed: 17 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg